CLINICAL_TRIALS
trial_result
· 2016-09-09
Clinical Trial Update: The Effects of Nitric Oxide for Inhalation in Right Ventricular Infarction Patients [Phase 2]
Summary
Phase 2 trial evaluating inhaled nitric oxide in patients with right ventricular infarction has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mallinckrodt | Conditions: Right Ventricular Infarction | Phase 2 | Status: TERMINATED